instnjctions): The overall aim is to gain a better understanding of the manner in which general anesthetics interact with the activated states of the ligand-gated ion channels of the Cys-loop superfamily. The overall hypothesis is that general anesthetics interact with these channels at allosteric sites whose properties vary with the channel's conformational state. A given binding site's size and affinity for anesthetics varies with time as the receptor changes its conformation following addition of agonist. The approach is structured to encourage a tight integration between kinetic and structural approaches with kinetic studies generating hypotheses about the relative affinity of anesthetics for specific transient conformational states and time-resolved freeze quenched photolabeling being used to detemriine the degree of photoincorporation and to locate anesthetic sites.
Aims 1 and 2 probe the mechanisms and binding sites involved in anesthetic enhancement of agonist- induced ion currents.
Aim 1 addresses this issue for the cationic members of the family where only the smallest anesthetics enhance currents. The specific hypothesis to be tested is that the enhancing site increases in size as the receptor passes from the closed to the open and then desensitized states. The kinetics of this are most easily dissected on the slowest member of the superfamily, the human neuronal 5 HT3AR.
Aim 2 will locate the enhancing site in human neuronal GABAARs in collaboration with Project 3 and using photoactivable anesthetics from the etomidate, propofol, barbiturate and alcohol families. The second part of this aim asks whether the site at which etomidate itself activates GABA currents is the same as that which enhances agonist-induced currents.
Aim 3 explores the role of binding sites at the subunit interface vs. those in the ion channel in inhibition and enhancement using probes specifically designed for the task. This work will use the Torpedo acetylcholine receptor because its known structure will facilitate interpretation. In each aim, the receptor chosen is that best suited to answering the question. Photolabels and purified, heterologously expressed receptors will be provided by the Synthetic Chemistry and Protein Production Cores respectively, and sequencing by the Protein Chemistry Core.
|Woll, Kellie A; Zhou, Xiaojuan; Bhanu, Natarajan V et al. (2018) Identification of binding sites contributing to volatile anesthetic effects on GABA type A receptors. FASEB J 32:4172-4189|
|McGrath, Megan; Yu, Zhiyi; Jayakar, Selwyn S et al. (2018) Etomidate and Etomidate Analog Binding and Positive Modulation of ?-Aminobutyric Acid Type A Receptors: Evidence for a State-dependent Cutoff Effect. Anesthesiology 129:959-969|
|Feng, Hua-Jun; Forman, Stuart A (2018) Comparison of ??? and ??? GABAA receptors: Allosteric modulation and identification of subunit arrangement by site-selective general anesthetics. Pharmacol Res 133:289-300|
|McGrath, Megan; Ma, Celena; Raines, Douglas E (2018) Dimethoxy-etomidate: A Nonhypnotic Etomidate Analog that Potently Inhibits Steroidogenesis. J Pharmacol Exp Ther 364:229-237|
|Zhou, Xiaojuan; Desai, Rooma; Zhang, Yinghui et al. (2018) High-level production and purification in a functional state of an extrasynaptic gamma-aminobutyric acid type A receptor containing ?4?3? subunits. PLoS One 13:e0191583|
|Ziemba, Alexis M; Szabo, Andrea; Pierce, David W et al. (2018) Alphaxalone Binds in Inner Transmembrane ?+-?- Interfaces of ?1?3?2 ?-Aminobutyric Acid Type A Receptors. Anesthesiology 128:338-351|
|Forman, Stuart A (2018) Combining Mutations and Electrophysiology to Map Anesthetic Sites on Ligand-Gated Ion Channels. Methods Enzymol 602:369-389|
|Ma, Celena; Pejo, Ervin; McGrath, Megan et al. (2017) Competitive Antagonism of Anesthetic Action at the ?-Aminobutyric Acid Type A Receptor by a Novel Etomidate Analog with Low Intrinsic Efficacy. Anesthesiology 127:824-837|
|Jounaidi, Youssef; Cotten, Joseph F; Miller, Keith W et al. (2017) Tethering IL2 to Its Receptor IL2R? Enhances Antitumor Activity and Expansion of Natural Killer NK92 Cells. Cancer Res 77:5938-5951|
|Yu, Zhiyi; Cohen, Jonathan B (2017) Enantiomeric barbiturates bind distinct inter- and intrasubunit binding sites in a nicotinic acetylcholine receptor (nAChR). J Biol Chem 292:17258-17271|
Showing the most recent 10 out of 116 publications